In a clinical evaluation where results from the SCoV-2 Ag Detect™ Rapid Self-Test were compared to an FDA EUA authorized molecular SARS-CoV-2 test, the SCoV-2 Ag Detect™ Rapid Self-Test correctly identified 85.7% of positive specimens and 100% of negative specimens. The performance of this test is still being studied in patients without signs and symptoms of respiratory infection and for serial testing. Performance may differ in these populations.
Leave A Comment